204 related articles for article (PubMed ID: 19440072)
1. Association of posttraumatic stress disorder with increased prevalence of metabolic syndrome.
Jin H; Lanouette NM; Mudaliar S; Henry R; Folsom DP; Khandrika S; Glorioso DK; Jeste DV
J Clin Psychopharmacol; 2009 Jun; 29(3):210-5. PubMed ID: 19440072
[TBL] [Abstract][Full Text] [Related]
2. Increased Framingham 10-year risk of coronary heart disease in middle-aged and older patients with psychotic symptoms.
Jin H; Folsom D; Sasaki A; Mudaliar S; Henry R; Torres M; Golshan S; Glorioso DK; Jeste D
Schizophr Res; 2011 Feb; 125(2-3):295-9. PubMed ID: 21093219
[TBL] [Abstract][Full Text] [Related]
3. High-density lipoprotein-cholesterol and antipsychotic medication in overweight inpatients with schizophrenia: post-hoc analysis of a Japanese nationwide survey.
Ono S; Sugai T; Suzuki Y; Yamazaki M; Shimoda K; Mori T; Ozeki Y; Matsuda H; Sugawara N; Yasui-Furukori N; Okamoto K; Sagae T; Someya T
BMC Psychiatry; 2018 Jun; 18(1):180. PubMed ID: 29879941
[TBL] [Abstract][Full Text] [Related]
4. Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization.
Jin H; Shih PA; Golshan S; Mudaliar S; Henry R; Glorioso DK; Arndt S; Kraemer HC; Jeste DV
J Clin Psychiatry; 2013 Jan; 74(1):10-8. PubMed ID: 23218100
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome in schizophrenia: a comparative study of antipsychotic-free/naïve and antipsychotic-treated patients from India.
Pallava A; Chadda RK; Sood M; Lakshmy R
Nord J Psychiatry; 2012 Jun; 66(3):215-21. PubMed ID: 22017264
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of the metabolic syndrome in Danish psychiatric outpatients treated with antipsychotics.
Krane-Gartiser K; Breum L; Glümrr C; Linneberg A; Madsen M; Køster A; Jepsen PW; Fink-Jensen A
Nord J Psychiatry; 2011 Oct; 65(5):345-52. PubMed ID: 21428861
[TBL] [Abstract][Full Text] [Related]
7. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
8. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
9. Effects of switching from olanzapine to risperidone on the prevalence of the metabolic syndrome in overweight or obese patients with schizophrenia or schizoaffective disorder: analysis of a multicenter, rater-blinded, open-label study.
Meyer JM; Pandina G; Bossie CA; Turkoz I; Greenspan A
Clin Ther; 2005 Dec; 27(12):1930-41. PubMed ID: 16507379
[TBL] [Abstract][Full Text] [Related]
10. Off-Label Prescribing of Second-Generation Antipsychotics to Elderly Veterans with Posttraumatic Stress Disorder and Dementia.
Semla TP; Lee A; Gurrera R; Bajor L; Li M; Miller DR; Smith EG; Wang C; Wan Y; Kazis LE; Bauer MS
J Am Geriatr Soc; 2017 Aug; 65(8):1789-1795. PubMed ID: 28369688
[TBL] [Abstract][Full Text] [Related]
11. Comparison of metabolic syndrome incidence among schizophrenia patients treated with aripiprazole versus olanzapine or placebo.
L'Italien GJ; Casey DE; Kan HJ; Carson WH; Marcus RN
J Clin Psychiatry; 2007 Oct; 68(10):1510-6. PubMed ID: 17960964
[TBL] [Abstract][Full Text] [Related]
12. [Metabolic side effects of risperidone in early onset schizophrenia].
Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome in outpatients receiving antipsychotic therapy in routine clinical practice: a cross-sectional assessment of a primary health care database.
Sicras-Mainar A; Blanca-Tamayo M; Rejas-Gutiérrez J; Navarro-Artieda R
Eur Psychiatry; 2008 Mar; 23(2):100-8. PubMed ID: 17904825
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic prescriptions in Iraq and Afghanistan veterans with posttraumatic stress disorder in Department of Veterans Affairs healthcare, 2007-2012.
Cohen BE; Shi Y; Neylan TC; Maguen S; Seal KH
J Clin Psychiatry; 2015 Apr; 76(4):406-12. PubMed ID: 25845036
[TBL] [Abstract][Full Text] [Related]
15. Assessment of cardiovascular disease risk in patients with schizophrenia spectrum disorders in German psychiatric hospitals: results of the pharmacoepidemiologic CATS study.
Deuschle M; Paul F; Brosz M; Bergemann N; Franz M; Kammerer-Ciernioch J; Lautenschlager M; Lederbogen F; Roesch-Ely D; Weisbrod M; Kahl KG; Reichmann J; Gross J; Umbreit J
Soc Psychiatry Psychiatr Epidemiol; 2013 Aug; 48(8):1283-8. PubMed ID: 23515714
[TBL] [Abstract][Full Text] [Related]
16. The METEOR study: frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs.
Falissard B; Mauri M; Shaw K; Wetterling T; Doble A; Giudicelli A; De Hert M
Int Clin Psychopharmacol; 2011 Nov; 26(6):291-302. PubMed ID: 21876442
[TBL] [Abstract][Full Text] [Related]
17. Obstructive Sleep Apnea in Posttraumatic Stress Disorder Comorbid With Mood Disorder: Significantly Higher Incidence Than in Either Diagnosis Alone.
Fehr BS; Katz WF; Van Enkevort EA; Khawaja IS
Prim Care Companion CNS Disord; 2018 Aug; 20(4):. PubMed ID: 30107101
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome and antipsychotic monotherapy treatment among schizophrenia patients in Malaysia.
Said MA; Hatim A; Habil MH; Zafidah W; Haslina MY; Badiah Y; Ramli MA; Ananjit S; Sapini Y; Shah M; Mahmud B; Bulgiba A; Hairi NN
Prev Med; 2013; 57 Suppl():S50-3. PubMed ID: 23337566
[TBL] [Abstract][Full Text] [Related]
19. Latent Toxoplasma gondii infection is associated with decreased serum triglyceride to high-density lipoprotein cholesterol ratio in male patients with schizophrenia.
Sagud M; Vlatkovic S; Svob Strac D; Sviben M; Zivkovic M; Vilibic M; Vuksan-Cusa B; Mihaljevic-Peles A; Pivac N
Compr Psychiatry; 2018 Apr; 82():115-120. PubMed ID: 29477703
[TBL] [Abstract][Full Text] [Related]
20. Protective Effects of Quetiapine on Metabolic and Inflammatory Abnormalities in Schizophrenic Patients during Exacerbated Stage.
Kao YC; Ko CY; Wang SC; Liu YP
Chin J Physiol; 2016 Apr; 59(2):69-77. PubMed ID: 27080462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
